Evidence map›Paper›PMID 29614983›Full record

ArticleBMC cancer2018

Compared characteristics of current vs. past smokers at the time of diagnosis of a first-time lung or head and neck cancer: a cross-sectional study.

Corinne Vannimenus, Hélène Bricout, Olivier Le Rouzic, François Mouawad, Dominique Chevalier, Eric Dansin, Laurence Rotsaert, Gautier Lefebvre, Olivier Cottencin, Henri Porte and 5 more

Registry-linked trialAbstract read
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01647425 (Prevalence and Risk Factors for Persistent Tobacco or Alcohol Use Over the First Year of a First Lung or Head and Neck Cancer), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01647425 completednot on this map

Prevalence and Risk Factors for Persistent Tobacco or Alcohol Use Over the First Year of a First Lung or Head and Neck Cancer

TypeobservationalSponsorCentre Oscar LambretRan2012 to 2014Enrolled385ConditionsHead and Neck Cancer, Lung CancerArmsphysician assessment
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Role of Cannabinoids in Oral Cancer.International journal of molecular sciences · 2024
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Corinne VannimenusService de Tabacologie, Clinique de Pneumologie, Hôpital Calmette, CHRU de Lille CS70001, 59037, Lille cedex, France. corinne.vannimenus@chru-lille.fr.
Hélène BricoutCentre de Référence Régionale en Cancérologie, Lille, France.
Olivier Le RouzicService de Tabacologie, Clinique de Pneumologie, Hôpital Calmette, CHRU de Lille CS70001, 59037, Lille cedex, France.
François MouawadService d'Oto-rhino-laryngologie, CHRU de Lille, Lille, France.
Dominique ChevalierService d'Oto-rhino-laryngologie, CHRU de Lille, Lille, France.
Eric DansinDépartement de Cancérologie Cervico-Faciale, Centre de Lutte Contre le Cancer Oscar Lambret, Lille, France.
Laurence RotsaertDépartement de Cancérologie Cervico-Faciale, Centre de Lutte Contre le Cancer Oscar Lambret, Lille, France.
Gautier LefebvreDépartement de Cancérologie Cervico-Faciale, Centre de Lutte Contre le Cancer Oscar Lambret, Lille, France.
Olivier CottencinService d'Addictologie, CHRU de Lille, Lille, France.
Henri PorteClinique de Chirurgie Thoracique, CHRU de Lille, Lille, France.
Arnaud ScherpereelService de Tabacologie, Clinique de Pneumologie, Hôpital Calmette, CHRU de Lille CS70001, 59037, Lille cedex, France.
Asmaa El FahsiCentre de Référence Régionale en Cancérologie, Lille, France.
Florence RichardSanté Publique et Epidémiologie, Institut Pasteur, Université de Lille, INSERM UMR744, Lille, France.
Benjamin RollandUniv Lyon; UCBL; INSERM U1028 ; CNRS UMR5292 ; Service Universitaire d'Addictologie de Lyon, CH le Vinatier, Lyon, France.ORCID 0000-0002-8666-3635
ALTAK Study Group

Funding

Institut National Du Cancer #RECF1764
6 · The paper itself

Abstract

backgroundActive smoking at the time of diagnosis of a first head & neck (H&N) or lung cancer is associated with a worse cancer outcome and increased mortality. However, the compared characteristics of active vs. former smokers at cancer diagnosis are poorly known.

methodsIn 371 subjects with a first H&N or lung cancer, we assessed: 1) socio-demographic features; 2) lifelong types of smoking; 3) alcohol use disorder identification test (AUDIT); 4) cannabis abuse screening test (CAST); and 5) Mini International Neuropsychiatric Interview (MINI). Using a multivariable regression model, we compared the profile of current smokers and past smokers.

resultsCurrent smokers more frequently exhibited H&N cancer (OR 3.91; 95% CI [2.00-6.51]; p <  0.0001) and ever smoking of hand-rolled cigarettes (OR 2.2; 95% CI [1.25-3.88]; p = 0.007). Among subjects with lung cancer (n = 177), current smoking was primarily associated with ever smoking of hand-rolled cigarettes (OR 2.88; 95% CI [1.32-6.30]; p = 0.008) and negatively associated with age (OR 0.92; 95% CI [0.89-0.96]; p <  0.001). Among subjects with H&N cancer (n = 163), current smokers exhibited a significantly greater AUDIT score (OR = 1.08; 95% CI [1.01-1.16]; p = 0.03).

conclusionAt the time of diagnosis of the first lung or H&N cancer, current smoking is highly associated with previous type of smoking and alcohol drinking patterns.

trial registrationNCT01647425 ; Registration date: July 23, 2012.

Indexed as

SmokersSmokingAgedCross-Sectional StudiesFemaleHead and Neck NeoplasmsHumansLung NeoplasmsMaleMiddle AgedOdds RatioPopulation SurveillanceRisk AssessmentRisk FactorsTime FactorsAlcohol-related disordersHead & Neck NeoplasmsLung neoplasmsTobacco use

Identifiers

PMID29614983
PMCPMC5883294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.